Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Bis(4-methyl-imidazolium) succinate succinic acid solvate.

ABSTRACT: In the title compound, 2C(4)H(7)N(2) (+)·C(4)H(4)O(4) (2-)·C(4)H(6)O(4), the asymmetric unit consists of two 4-methyl-imidazolium cations, one succinate dianion and one netrual succinic acid mol-ecule and within the latter components, the C-O, C=O and C O bonds are clearly evidenced from their relative distances. In the crystal structure, the individual components are linked by inter-molecular N-H?O, O-H?O and C-H?O hydrogen bonds into a two-dimensional network parallel to the (101) plane in which R(3) (3)(9), R(3) (3)(12) and R(4) (4)(18) hydrogen-bond motifs are present.

SUBMITTER: Du G

PROVIDER: S-EPMC2968489 | biostudies-literature | 2009 Feb

REPOSITORIES: biostudies-literature

ACCESS DATA

Json Xml

Publications

Bis(4-methyl-imidazolium) succinate succinic acid solvate.

Du Guihuan G Liu Zuli Z Chu Qian Q Li Zhen Z Zhang Suming S

Acta crystallographica. Section E, Structure reports online 20090225 Pt 3

In the title compound, 2C(4)H(7)N(2) (+)·C(4)H(4)O(4) (2-)·C(4)H(6)O(4), the asymmetric unit consists of two 4-methyl-imidazolium cations, one succinate dianion and one netrual succinic acid mol-ecule and within the latter components, the C-O, C=O and C O bonds are clearly evidenced from their relative distances. In the crystal structure, the individual components are linked by inter-molecular N-H⋯O, O-H⋯O and C-H⋯O hydrogen bonds into a two-dimensional network parallel to the (101) plane in whi ...[more]

PMID: 21582261

Similar Datasets

Bis(melaminium) succinate succinic acid monosolvate dihydrate.

Project description:The asymmetric unit of the solvated title salt, 2C(3)H(7)N(6) (+)·C(4)H(4)O(4) (2-)·C(4)H(6)O(4)·2H(2)O, contains one essentially planar melaminium (2,4,6-triamino-1,3,5-triazin-1-ium) cation (r.m.s. deviation of the non-H atoms = 0.0097 Å), one-half of a succinate anion, one-half of a succinic acid solvent mol-ecule and one water molecule of crystallization; full mol-ecules are generated by inversion symmetry. Supra-molecular layers parallel to (12-1) are formed through extensive inter-molecular hydrogen bonding of the types O-H⋯O, N-H⋯N and N-H⋯O between the components.

| S-EPMC3414998 | biostudies-literature

Bis(2-amino-thia-zolium) succinate succinic acid.

Project description:In the title compound, 2C(3)H(5)N(2)S(+)·C(4)H(4)O(4) (2-)·C(4)H(6)O(4), the thia-zolium ring is almost planar, with the maximum deviation from planarity being 0.0056 (8) Å for the C atom carrying the amine substituent. The N atom of the 2-amino-thia-zole mol-ecule is protonated. Both the anion and the acid lie across inversion centres. The crystal packing is consolidated by inter-molecular O-H⋯O, N-H⋯O and C-H⋯O hydrogen bonds. Mol-ecules are stacked down the b axis.

| S-EPMC2968937 | biostudies-literature

Bis(ethano-laminium) succinate-succinic acid (1/1).

Project description:The asymmetric unit of the title compound, 2C(2)H(8)NO(+)·C(4)H(4)O(4) (2-)·C(4)H(6)O(4), consists of half a succinate anion, half a succinic acid mol-ecule and one ethano-laminium cation. The succinate anion and succinic acid mol-ecule, both of which are located on inversion centres, are linked by O-H⋯O hydrogen bonds, forming a chain along the [2[Formula: see text]0] direction. The chain and the ethano-laminium cation are further connected by O-H⋯O and N-H⋯O hydrogen bonds.

| S-EPMC3200711 | biostudies-literature

Crystal structure of the bis-(cyclo-hexyl-ammonium) succinate succinic acid salt adduct.

Project description:The crystal structure of the title salt adduct, 2C6H14N(+)·C4H4O4 (2-)·C4H6O4, consists of two cyclo-hexyl-ammonium cations, one succcinate dianion and one neutral succinic acid mol-ecule. Succinate dianions and succinic acid mol-ecules are self-assembled head-to-tail through O-H⋯O hydrogen bonds and adopt a syn-syn configuration, leading to a strand-like arrangement along [101]. The cyclo-hexyl-ammonium cations have a chair conformation and act as multidentate hydrogen-bond donors linking adjacent strands through inter-molecular N-H⋯O inter-actions to both the succinate and the succinic acid components. This results in two-dimensional supra-molecular layered structures lying parallel to (010).

| S-EPMC4571351 | biostudies-literature

Bis(2-methyl-imidazolium) chloranilate.

Project description:The asymmetric unit of the title structure, 2C(4)H(7)N(2) (+)·C(6)Cl(2)O(4) (2-), consists of one 2-methyl-imidazolium cation and one-half of a chloranilate anion, the formula unit being generated by crystallographic inversion symmetry. N-H?O hydrogen bonds link the ions into a two-dimensional framework parallel to the (102) plane. No ?-? stacking or C-H?? inter-actions are observed in the crystal structure.

| S-EPMC2914992 | biostudies-literature

Bis(2-methyl-imidazolium) fumarate dihydrate.

Project description:In the title compound, 2C(4)H(7)N(2) (+)·C(4)H(2)O(4) (2-)·2H(2)O, the asymmetric unit consists of one 2-methyl-imidazolium cation, half a fumarate dianion and one water mol-ecule. There is an inversion center at the mid-point of the central C-C bond of the fumarate anion. In the crystal structure, mol-ecules are linked into a three-dimensional network by inter-molecular N-H?O, O-H?O and weak C-H?O hydrogen bonds. In addition, there are weak ?-? stacking inter-actions with centroid-centroid distances of 3.640?(1)?Å.

| S-EPMC2971242 | biostudies-literature

Bis(1,3-dimethyl-1H-imidazolium) hexa-fluoro-silicate methanol 0.33-solvate.

Project description:The title compound, 6C5H9N2 (+)·3SiF6 (2-)·CH3OH, (I), was prepared by recrystallization of the crude salt from methanol along with solvent-free 2C5H9N2 (+)·SiF6 (2-) (II). Crystals of these solvatomorphs can be separated manually. The solvate (I) crystallizes in a rare hexa-gonal space group P6/mcc. Its asymmetric unit comprises one half of an imidazolium cation bis-ected by the crystallographic m-plane, one-sixth and one-twelfth of two crystallographically independent SiF6 (2-) dianions (Si atoms are located on the 3.2 and 6/m inversion centres), and one-twelfth of a methanol mol-ecule (C atoms are situated on the 622 inversion centres, other atoms are disordered between general positions). In (I), all F atoms of 3.2-located SiF6 (2-) dianions participate in the formation of symmetry-equivalent contacts to the H atoms of imidazolium fragments, thus forming rod-type ensembles positioned on the -6 axes. These 'pillar' rods are, in turn, F?H inter-linked through SiF6 (2-) dianions disordered around the 6/m centres. The twelvefold disordered methanol mol-ecules are appended to this array by O-H?F hydrogen bonds to the 6/m located SiF6 (2-) dianions. In terms of graph-set notation, the first and second level networks in (I) are N 1 = C 2 (2)(7)[3R 4 (4)(14)]D 2 (2)(4) and N 2 = D 2 (2)(5) (C-H?O hydrogen bonds are not considered). After locating all symmetrically independent atoms in the cation and anions, there remained a strong (> 3 e Å(-3)) residual electron density peak located at the 622 inversion centre. Treatment of this pre-refined model with the SQUEEZE procedure in PLATON [Spek (2009). Acta Cryst. D65, 148-155] revealed two voids per unit cell, indicative of the presence of the solvent methanol mol-ecule disordered about the 622 inversion centre.

| S-EPMC3793724 | biostudies-literature

Crystal structures of 2-methyl-pyridinium hydrogen 2,3-bis-(4-methyl-benzo-yloxy)succinate and bis-[4-methyl-pyridinium hydrogen 2,3-bis-(4-methyl-benzo-yloxy)succinate] penta-hydrate.

Project description:The title salt (I), C6H8N+·C20H17O8-, comprises a 2-methyl-pyridinium cation and a 2,3-bis-(4-methyl-benzo-yloxy)succinate mono-anion while the salt (II), 2C6H8N+·2C20H17O8-·5H2O, consists of a pair of 4-methyl-pyridinium cations and 2,3-bis-(4-methyl-benzo-yloxy)succinate mono-anions and five water mol-ecules of solvation in the asymmetric unit. In (I), the dihedral angle between the aromatic rings of the anion is 40.41 (15)°, comparing with 43.0 (3) and 85.7 (2)° in the conformationally dissimilar anion mol-ecules in (II). The pyridine ring of the cation in (I) is inclined at 23.64 (16) and 42.69 (17)° to the two benzene moieties of the anion. In (II), these comparative values are 4.7 (3), 43.5 (3)° and 43.5 (3), 73.1 (3)° for the two associated cation and anion pairs. The crystal packing of (I) is stabilized by inter-ionic N-H⋯O, O-H⋯O and C-H⋯O hydrogen bonds as well as weak C-H⋯π inter-actions, linking the ions into infinite chains along [100]. In the crystal packing of (II), the anions and cations are also linked by N-H⋯O and O-H⋯O hydrogen bonds involving also the water mol-ecules, giving a two-dimensional network across (001). The crystal structure is also stabilized by weak C-H⋯O and C-H⋯π inter-actions.

| S-EPMC5730300 | biostudies-literature

1,3-Bis(carboxy-meth-yl)imidazolium triiodide 1-carboxyl-atomethyl-3-carboxy-methyl-imidazolium.

Project description:In the title compound, C(7)H(9)N(2)O(4) (+)·I(3) (-)·C(7)H(8)N(2)O(4), the two imidazolium units are hydrogen bonded through the carboxyl groups. The units are further linked via inter-molecular O-H?O hydrogen bonding, resulting in a one-dimensional ladder-type structure. As a result, the two carb-oxy groups of each imidazolium unit adopt a cis configuration with respect to the imidazolium ring.

| S-EPMC2977287 | biostudies-literature

Bis(1-benzyl-3-methyl-imidazolium-κC)mercury(II) bis-(hexa-fluoridophosphate).

Project description:The asymmetric unit of the title complex, [Hg(C(11)H(12)N(2))(2)](PF(6))(2), consists of one bis-(1-benzyl-3-methyl-imidazolium)mercury(II) cation, one half of the cation and an additional Hg(II) atom, which lies on an inversion centre, and three hexa-fluorido-phosphate anions. The Hg(II) atoms exist in a linear coordination geometry [C-Hg-C = 178.9 (2) and 180°] formed by two carbene C atoms from the imidazole rings. In the crystal, the cations and anions are connected via C-H⋯F hydrogen bonds, forming a three-dimensional network.

| S-EPMC3200814 | biostudies-literature

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data